Prednisolone Deemed Safe, Effective First-Line Acute Gout RxLast Updated: February 23, 2016. For patients with acute gout, prednisolone has similar analgesic effectiveness to indomethacin, according to a study published online Feb. 23 in the Annals of Internal Medicine.
TUESDAY, Feb. 23, 2016 (HealthDay News) -- For patients with acute gout, prednisolone has similar analgesic effectiveness to indomethacin, according to a study published online Feb. 23 in the Annals of Internal Medicine.
Timothy Hudson Rainer, M.D., from the Chinese University of Hong Kong, and colleagues compared the effectiveness and safety of oral prednisolone versus oral indomethacin in patients presenting to emergency departments with acute gout. A total of 376 patients, aged 18 years or older, were randomized to receive either indomethacin or prednisolone. Patient outcomes were assessed during the first two hours in the emergency department and from days one to 14.
The researchers observed equivalent and clinically significant within-group reductions in the mean pain score with indomethacin and prednisolone in the emergency department and from days one to 14. During the study there were no major adverse events. Patients in the indomethacin group had more minor adverse events during the emergency department phase than patients in the prednisolone group (19 versus 6 percent; P < 0.001). Thirty-seven percent of patients in each group had minor adverse events during days one to 14.
"Oral prednisolone and indomethacin had similar analgesic effectiveness among patients with acute gout," the authors write. "Prednisolone is an effective and safe first-line option for treatment of acute gout."
|Previous: Cutting Radiation Exposure Still Yields Acceptable CT Quality||Next: SCCM: Peri-Op Statins Don’t Cut Risk of AKI in Cardiac Surgery|
Reader comments on this article are listed below. Review our comments policy.